Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa
Epistemonikos ID: fdc48d00e93a66d1f7730ff1df4b10bb5d66d63a
First added on: Nov 25, 2025